RxDoctor Payments Data

James Moore, DO

Family Medicine · Farmington, MONPI 1134171531

Payments from drug & device makers

$3,898in general payments, 2019–2025

Across 252 payments — averaging $15.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$502
  • Lilly USA, LLC$285
  • AstraZeneca$270
  • Amarin Pharma, Inc.$251
  • Pfizer$231
  • plus $1K from 19 others

What the payments were for

  • Food & beverage$3,898100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,898 in reported general payments places this provider in the 85th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$105,816
Medicare patients
324
Services billed
2,052

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban58$44,182
TrulicityDulaglutide34$37,498
OzempicSemaglutide19$30,566
RybelsusSemaglutide15$24,972
JardianceEmpagliflozin21$24,763
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$21,349
MounjaroTirzepatide12$18,326
FarxigaDapagliflozin Propanediol14$17,496
VascepaIcosapent Ethyl31$12,296
Breztri AerosphereBudesonide/Glycopyr/Formoterol14$11,254
SymbicortBudesonide/Formoterol Fumarate19$8,991
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen408$8,751
ArexvyRsvpref3 Antigen/As01e/Pf27$7,639
Tresiba Flextouch U-100Insulin Degludec11$7,118
Icosapent Ethyl30$6,082

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$285$55,82446 claims
Novo NordiskOzempic, Rybelsus$502$55,53934 claims
PfizerEliquis$231$44,18258 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$270$37,74147 claims
GSKTrelegy Ellipta, Arexvy$85$28,98858 claims
AbbVieSynthroid$1,268$1,54946 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Farmington

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →